Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
AbstractMaking a diagnosis of Kawasaki disease with certainty may be challenging, especially since the recognition of cases with incomplete diagnostic criteria and its consequences. In order to build the diagnostic case in daily practice, clinicians rely on clinical criteria established over four decades ago, aided by non specific laboratory tests, and above all inspired by experience. We have recently studied the diagnostic value of N-terminal pro B-type natriuretic peptide to improve the diagnostic certainty of cases with complete or incomplete clinical criteria. Our working hypothesis was based on the fact that myocarditis is present in nearly all Kawasaki disease patients supported by histology data. In this paper, we review these facts and the myocardial perspective from the diagnostic and the mechanistic standpoints. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Dahdah, N.; Fournier, A. Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective. Diagnostics 2013, 3, 1-12.
Dahdah N, Fournier A. Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective. Diagnostics. 2013; 3(1):1-12.Chicago/Turabian Style
Dahdah, Nagib; Fournier, Anne. 2013. "Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective." Diagnostics 3, no. 1: 1-12.